Portland Hill Asset Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-49,400
Closed -$465K 39
2022
Q4
$465K Hold
49,400
1.29% 16
2022
Q3
$496K Hold
49,400
0.92% 17
2022
Q2
$462K Hold
49,400
0.63% 18
2022
Q1
$483K Hold
49,400
0.44% 20
2021
Q4
$481K Hold
49,400
0.37% 21
2021
Q3
$479K Buy
+49,400
New +$478K 0.32% 22

Other funds holding COCH

Portland Hill Asset Management's COCH Position: Q1 2023 in Review

Portland Hill Asset Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 49,400 shares — an estimated $465K sold.

Portland Hill Asset Management first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $496K in Q3 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Portland Hill Asset Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Portland Hill Asset Management sold 49,400 Envoy Medical shares in Q1 2023, an estimated $465K.
  • Portland Hill Asset Management first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
  • Portland Hill Asset Management's Envoy Medical position peaked at $496K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Portland Hill Asset Management's 13F filing for Q1 2023, filed 12 May 2023.